| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.001 | 1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |